ClinicalTrials.gov
ClinicalTrials.gov Menu

Assessment of the Optimal Dosing of Piperacillin-tazobactam in Intensive Care Unit Patients: Extended Versus Continuous Infusion

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01198925
Recruitment Status : Completed
First Posted : September 10, 2010
Last Update Posted : May 11, 2018
Sponsor:
Information provided by (Responsible Party):
University Hospital, Ghent

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : November 16, 2012
  Actual Study Completion Date : May 3, 2018